comparemela.com
Home
Live Updates
FDA Grants Pemivibart Emergency Use Authorization for PrEP of COVID-19 in Immunocompromised Patients : comparemela.com
FDA Grants Pemivibart Emergency Use Authorization for PrEP of COVID-19 in Immunocompromised Patients
The indication is for adults and adolescents with moderate to severe immune compromise due to medical conditions or immunosuppressive medications and treatments.
Related Keywords
Cameronr Wolfe
,
Dave Hering
,
Deficiency Foundation
,
Duke University School Of Medicine
,
Invivyd Inc
,
Adults With Immune Compromise
,
Participants Aged
,
Older Who Are
,
Duke University School
,
Jorey Berry
,
Immune Deficiency Foundation
,
Immunocompromised Collaborative
,
comparemela.com © 2020. All Rights Reserved.